Diabetes 53:3020-3023, 2004
© 2004 by the American Diabetes Association, Inc.
Replication of an Association Between the Lymphoid Tyrosine Phosphatase Locus (LYP/PTPN22) With Type 1 Diabetes, and Evidence for Its Role as a General Autoimmunity Locus
Deborah Smyth1,
Jason D. Cooper1,
Joanne E. Collins2,
Joanne M. Heward2,
Jayne A. Franklyn2,
Joanna M.M. Howson1,
Adrian Vella1,
Sarah Nutland1,
Helen E. Rance1,
Lisa Maier1,
Bryan J. Barratt3,
Cristian Guja4,
Constantin Ionescu-Tîrgovi te4,
David A. Savage5,
David B. Dunger6,
Barry Widmer6,
David P. Strachan7,
Susan M. Ring8,
Neil Walker1,
David G. Clayton1,
Rebecca C.J. Twells1,
Stephen C.L. Gough2, and
John A. Todd1
1 Juvenile Diabetes Research Foundation (JDRF)/Wellcome Trust (WT) Diabetes and Inflammation Laboratory, Cambridge Institute for Medical Research (CIMR), University of Cambridge, Cambridge, U.K
2 Division of Medical Sciences, University of Birmingham, Birmingham, U.K
3 AstraZeneca, Macclesfield, U.K
4 Clinic of Diabetes, Institute of Diabetes, Nutrition and Metabolic Diseases "N. Paulescu," Bucharest, Romania
5 Department of Medical Genetics, Queens University Belfast, Belfast City Hospital, Belfast, Northern Ireland
6 Department of Paediatrics, Addenbrookes Hospital, University of Cambridge, Cambridge, U.K
7 Department of Public Health Sciences, St. Georges Hospital Medical School, London, U.K
8 Avon Longitudinal Study of Parents and Children (ALSPAC), University of Bristol, Bristol, U.K
In the genetic analysis of common, multifactorial diseases, such as type 1 diabetes, true positive irrefutable linkage and association results have been rare to date. Recently, it has been reported that a single nucleotide polymorphism (SNP), 1858C>T, in the gene PTPN22, encoding Arg620Trp in the lymphoid protein tyrosine phosphatase (LYP), which has been shown to be a negative regulator of T-cell activation, is associated with an increased risk of type 1 diabetes. Here, we have replicated these findings in 1,388 type 1 diabetic families and in a collection of 1,599 case and 1,718 control subjects, confirming the association of the PTPN22 locus with type 1 diabetes (family-based relative risk (RR) 1.67 [95% CI 1.461.91], and case-control odds ratio (OR) 1.78 [95% CI 1.542.06]; overall P = 6.02 x 1027). We also report evidence for an association of Trp620 with another autoimmune disorder, Graves disease, in 1,734 case and control subjects (P = 6.24 x 104; OR 1.43 [95% CI 1.171.76]). Taken together, these results indicate a more general association of the PTPN22 locus with autoimmune disease.
Address correspondence and reprint requests to Professor John A. Todd, Juvenile Diabetes Research Foundation (JDRF)/Wellcome Trust (WT) Diabetes and Inflammation Laboratory, Cambridge Institute for Medical Research (CIMR), University of Cambridge, Cambridge, U.K. E-mail: john.todd{at}cimr.cam.ac.uk

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
D. J. Smyth, J. D. Cooper, J. M.M. Howson, N. M. Walker, V. Plagnol, H. Stevens, D. G. Clayton, and J. A. Todd
PTPN22 Trp620 Explains the Association of Chromosome 1p13 With Type 1 Diabetes and Shows a Statistical Interaction With HLA Class II Genotypes
Diabetes,
June 1, 2008;
57(6):
1730 - 1737.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Zoledziewska, C. Perra, V. Orru, L. Moi, P. Frongia, M. Congia, N. Bottini, and F. Cucca
Further Evidence of a Primary, Causal Association of the PTPN22 620W Variant With Type 1 Diabetes
Diabetes,
January 1, 2008;
57(1):
229 - 234.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Rieck, A. Arechiga, S. Onengut-Gumuscu, C. Greenbaum, P. Concannon, and J. H. Buckner
Genetic Variation in PTPN22 Corresponds to Altered Function of T and B Lymphocytes
J. Immunol.,
October 1, 2007;
179(7):
4704 - 4710.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Bailey, J. D. Cooper, L. Zeitels, D. J. Smyth, J. H.M. Yang, N. M. Walker, E. Hypponen, D. B. Dunger, E. Ramos-Lopez, K. Badenhoop, et al.
Association of the Vitamin D Metabolism Gene CYP27B1 With Type 1 Diabetes
Diabetes,
October 1, 2007;
56(10):
2616 - 2621.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. ALARCON-RIQUELME
Recent Advances in the Genetics of Autoimmune Diseases
Ann. N.Y. Acad. Sci.,
September 1, 2007;
1110(1):
1 - 9.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
The International Multiple Sclerosis Genetics Cons
Risk Alleles for Multiple Sclerosis Identified by a Genomewide Study
N. Engl. J. Med.,
August 30, 2007;
357(9):
851 - 862.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. K. Kavvoura, T. Akamizu, T. Awata, Y. Ban, D. A. Chistiakov, I. Frydecka, A. Ghaderi, S. C. Gough, Y. Hiromatsu, R. Ploski, et al.
Cytotoxic T-Lymphocyte Associated Antigen 4 Gene Polymorphisms and Autoimmune Thyroid Disease: A Meta-Analysis
J. Clin. Endocrinol. Metab.,
August 1, 2007;
92(8):
3162 - 3170.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Sutherland, J. Davies, C. J. Owen, S. Vaikkakara, C. Walker, T. D. Cheetham, R. A. James, P. Perros, P. T. Donaldson, H. J. Cordell, et al.
Genomic Polymorphism at the Interferon-Induced Helicase (IFIH1) Locus Contributes to Graves' Disease Susceptibility
J. Clin. Endocrinol. Metab.,
August 1, 2007;
92(8):
3338 - 3341.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Heward, O. J. Brand, J. C. Barrett, J. D. Carr-Smith, J. A. Franklyn, and S. C. Gough
Association of PTPN22 Haplotypes with Graves' Disease
J. Clin. Endocrinol. Metab.,
February 1, 2007;
92(2):
685 - 690.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. H. Lee, Y. H. Rho, S. J. Choi, J. D. Ji, G. G. Song, S. K. Nath, and J. B. Harley
The PTPN22 C1858T functional polymorphism and autoimmune diseases--a meta-analysis
Rheumatology,
January 1, 2007;
46(1):
49 - 56.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Ikari, S. Momohara, E. Inoue, T. Tomatsu, M. Hara, H. Yamanaka, and N. Kamatani
Haplotype analysis revealed no association between the PTPN22 gene and RA in a Japanese population
Rheumatology,
November 1, 2006;
45(11):
1345 - 1348.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. S RICH, P. CONCANNON, H. ERLICH, C. JULIER, G. MORAHAN, J. NERUP, F. POCIOT, and J. A TODD
The Type 1 Diabetes Genetics Consortium.
Ann. N.Y. Acad. Sci.,
October 1, 2006;
1079:
1 - 8.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. M JAHROMI and G. S EISENBARTH
Genetic Determinants of Type 1 Diabetes Across Populations
Ann. N.Y. Acad. Sci.,
October 1, 2006;
1079(1):
289 - 299.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Onengut-Gumuscu, J. H. Buckner, and P. Concannon
A Haplotype-Based Analysis of the PTPN22 Locus in Type 1 Diabetes.
Diabetes,
October 1, 2006;
55(10):
2883 - 2889.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. A. Aly, A. Ide, M. M. Jahromi, J. M. Barker, M. S. Fernando, S. R. Babu, L. Yu, D. Miao, H. A. Erlich, P. R. Fain, et al.
Extreme genetic risk for type 1A diabetes
PNAS,
September 19, 2006;
103(38):
14074 - 14079.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Tsurumaru, E. Kawasaki, H. Ida, K. Migita, A. Moriuchi, K. Fukushima, T. Fukushima, N. Abiru, H. Yamasaki, S. Noso, et al.
Evidence for the Role of Small Ubiquitin-Like Modifier 4 as a General Autoimmunity Locus in the Japanese Population
J. Clin. Endocrinol. Metab.,
August 1, 2006;
91(8):
3138 - 3143.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. M. Gillespie
Type 1 diabetes: pathogenesis and prevention.
Can. Med. Assoc. J.,
July 18, 2006;
175(2):
165 - 170.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Smyth, J. D. Cooper, C. E. Lowe, S. Nutland, N. M. Walker, D. G. Clayton, and J. A. Todd
No Evidence for Association of OAS1 With Type 1 Diabetes in Unaffected Siblings or Type 1 Diabetic Cases.
Diabetes,
May 1, 2006;
55(5):
1525 - 1528.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Barker
Type 1 Diabetes-Associated Autoimmunity: Natural History, Genetic Associations, and Screening
J. Clin. Endocrinol. Metab.,
April 1, 2006;
91(4):
1210 - 1217.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Hinks, J. Worthington, and W. Thomson
The association of PTPN22 with rheumatoid arthritis and juvenile idiopathic arthritis
Rheumatology,
April 1, 2006;
45(4):
365 - 368.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Simmonds, J. M. Heward, J. Carr-Smith, H. Foxall, J. A. Franklyn, and S. C. L. Gough
Contribution of Single Nucleotide Polymorphisms within FCRL3 and MAP3K7IP2 to the Pathogenesis of Graves' Disease
J. Clin. Endocrinol. Metab.,
March 1, 2006;
91(3):
1056 - 1061.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. Taylor, S. C. Gough, P. J. Hunt, T. H. Brix, K. Chatterjee, J. M. Connell, J. A. Franklyn, L. Hegedus, B. G. Robinson, W. M. Wiersinga, et al.
A Genome-Wide Screen in 1119 Relative Pairs with Autoimmune Thyroid Disease
J. Clin. Endocrinol. Metab.,
February 1, 2006;
91(2):
646 - 653.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Traherne, L. F. Barcellos, S. J. Sawcer, A. Compston, P. P. Ramsay, S. L. Hauser, J. R. Oksenberg, and J. Trowsdale
Association of the truncating splice site mutation in BTNL2 with multiple sclerosis is secondary to HLA-DRB1*15
Hum. Mol. Genet.,
January 1, 2006;
15(1):
155 - 161.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Kahles, E. Ramos-Lopez, B. Lange, O. Zwermann, M. Reincke, and K. Badenhoop
Sex-specific association of PTPN22 1858T with type 1 diabetes but not with Hashimoto's thyroiditis or Addison's disease in the German population
Eur. J. Endocrinol.,
December 1, 2005;
153(6):
895 - 899.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. Florez
Editorial: Genetic Susceptibility for Polycystic Ovary Syndrome on Chromosome 19: Advances in the Genetic Dissection of Complex Reproductive Traits
J. Clin. Endocrinol. Metab.,
December 1, 2005;
90(12):
6732 - 6734.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Noso, H. Ikegami, T. Fujisawa, Y. Kawabata, K. Asano, Y. Hiromine, M. Tsurumaru, S. Sugihara, I. Lee, E. Kawasaki, et al.
Genetic Heterogeneity in Association of the SUMO4 M55V Variant With Susceptibility to Type 1 Diabetes
Diabetes,
December 1, 2005;
54(12):
3582 - 3586.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. C. L. Gough and M. C. O'Donovan
Clustering of metabolic comorbidity in schizophrenia: a genetic contribution?
J Psychopharmacol,
November 1, 2005;
19(6_suppl):
47 - 55.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Concannon, H. A. Erlich, C. Julier, G. Morahan, J. Nerup, F. Pociot, J. A. Todd, S. S. Rich, and the Type 1 Diabetes Genetics Consortium
Type 1 Diabetes: Evidence for Susceptibility Loci from Four Genome-Wide Linkage Scans in 1,435 Multiplex Families
Diabetes,
October 1, 2005;
54(10):
2995 - 3001.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C E Jennings, C J Owen, V Wilson, and S H S Pearce
A haplotype of the CYP27B1 promoter is associated with autoimmune Addison's disease but not with Graves' disease in a UK population
J. Mol. Endocrinol.,
June 1, 2005;
34(3):
859 - 863.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Zheng and J.-X. She
Genetic Association Between a Lymphoid Tyrosine Phosphatase (PTPN22) and Type 1 Diabetes
Diabetes,
March 1, 2005;
54(3):
906 - 908.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Simmonds and S. C. L. Gough
Genetic insights into disease mechanisms of autoimmunity
Br. Med. Bull.,
February 8, 2005;
71(1):
93 - 113.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2004 by the American Diabetes Association.
|
|
| |
|